MOLECULIGHT INC.

Matched from indexed company URL: MolecuLight, Inc.

FDA Registration(s)#

Registration, FEI, Name table
RegistrationFEINameStatusInitial importerExpiration yearAddress
30147040683014704068MOLECULIGHT INC.1N2026-01-01425 UNIVERSITY AVE TORONTO Ontario CA M5G1T6
30161639733016163973MOLECULIGHT CORP1Y2026-01-012403 Sidney St Ste 286 Pittsburgh PA US 15203

Registered Device Listings#

Registration key, Listing key, Premarket submission table
Registration keyListing keyPremarket submissionDeviceProduct codeDecision date
2240582046572023K213840MolecuLight I:XQJF2022-05-18
2240581089713233K211901MolecuLightDXQJF2021-07-21
2240581477016168K191371MolecuLight i:XQJF2019-12-04
2240581350702671
2240581522880096
2240581867668480

Product Codes Associated With Registrations#

Product code, Registration listing records, Latest decision table
Product codeRegistration listing recordsLatest decision
QJF32022-05-18

PMN#

GUDID#

MolecuLight i:X System - The MolecuLight i:X is a handheld imaging tool that allows clinicians diagnosing and treating skin wounds, at the point of care, to:(i) View and digitally record images of a wound,(ii) Measure and digitally record the size of a wound, and(iii) View and digitally record images of fluorescence emitted from a wound when exposed to an excitation light.The fluorescence image, when used in combination with clinical signs and symptoms, has been shown to increase the likelihood that clinicians can identify wounds containing bacterial loads >10^4 CFU per grams as compared to examination of clinical signs and symptoms alone. The MolecuLight i:X device should not be used to rule-out the presence of bacteria in a wound.

MolecuLight Inc

2022-01-04

MolecuLightDX System - The MolecuLightDX is a handheld imaging tool that allows clinicians diagnosing and treating skin wounds, at the point of care, to:(i) View and digitally record images of a wound, (ii) Measure and digitally record the size of a wound, and (iii) View and digitally record images of fluorescence emitted from a wound when exposed to an excitation light. The fluorescence image, when used in combination with clinical signs and symptoms, has been shown to increase the likelihood that clinicians can identify wounds containing bacterial loads >10^4 CFU per grams as compared to examination of clinical signs and symptoms alone. The MolecuLightDX device should not be used to rule-out the presence of bacteria in a wound.

MolecuLight Inc

2022-01-04